148 related articles for article (PubMed ID: 30439366)
1. Impairment of Vα24-Jα18
Zhao H; Li Z; Xie S; Luo Y; Zhou Y; Deng M; Zeng H; Zhao J; Yu L; Xu B
Exp Cell Res; 2019 Jan; 374(1):69-75. PubMed ID: 30439366
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
Molling JW; Kölgen W; van der Vliet HJ; Boomsma MF; Kruizenga H; Smorenburg CH; Molenkamp BG; Langendijk JA; Leemans CR; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
Int J Cancer; 2005 Aug; 116(1):87-93. PubMed ID: 15756674
[TBL] [Abstract][Full Text] [Related]
3. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
[TBL] [Abstract][Full Text] [Related]
4. Cord blood Vα24-Vβ11 natural killer T cells display a Th2-chemokine receptor profile and cytokine responses.
Harner S; Noessner E; Nadas K; Leumann-Runge A; Schiemann M; Faber FL; Heinrich J; Krauss-Etschmann S
PLoS One; 2011 Jan; 6(1):e15714. PubMed ID: 21305060
[TBL] [Abstract][Full Text] [Related]
5. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins.
Wu C; Li Z; Fu X; Yu S; Lao S; Yang B
Oncotarget; 2015 Oct; 6(30):28633-45. PubMed ID: 26416419
[TBL] [Abstract][Full Text] [Related]
7. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
Nieda M; Okai M; Tazbirkova A; Lin H; Yamaura A; Ide K; Abraham R; Juji T; Macfarlane DJ; Nicol AJ
Blood; 2004 Jan; 103(2):383-9. PubMed ID: 14512316
[TBL] [Abstract][Full Text] [Related]
9. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.
van der Vliet HJ; von Blomberg BM; Hazenberg MD; Nishi N; Otto SA; van Benthem BH; Prins M; Claessen FA; van den Eertwegh AJ; Giaccone G; Miedema F; Scheper RJ; Pinedo HM
J Immunol; 2002 Feb; 168(3):1490-5. PubMed ID: 11801694
[TBL] [Abstract][Full Text] [Related]
10. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.
Li Y; To K; Kanellakis P; Hosseini H; Deswaerte V; Tipping P; Smyth MJ; Toh BH; Bobik A; Kyaw T
Circ Res; 2015 Jan; 116(2):245-54. PubMed ID: 25398236
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.
Nishi N; van der Vliet HJ; Koezuka Y; von Blomberg BM; Scheper RJ; Pinedo HM; Giaccone G
Hum Immunol; 2000 Apr; 61(4):357-65. PubMed ID: 10715513
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Valpha24+Vbeta11+ NKT cells in peripheral blood of human kidney transplantation recipients.
Galante NZ; Ozaki KS; Cenedeze MA; Kallás EG; Salomão R; Pacheco-Silva A; Câmara NO
Int Immunopharmacol; 2005 Jan; 5(1):53-8. PubMed ID: 15589459
[TBL] [Abstract][Full Text] [Related]
13. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
[TBL] [Abstract][Full Text] [Related]
14. [Differences between CD3⁺ TCRvα24⁺ NKT cell and CD3⁺ TCRvβ11⁺ NKT cell in PBMC].
Li ZT; Yang BY; Wu CY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):949-53. PubMed ID: 21906465
[TBL] [Abstract][Full Text] [Related]
15. IL-21 Selectively Protects CD62L
Ngai H; Tian G; Courtney AN; Ravari SB; Guo L; Liu B; Jin J; Shen ET; Di Pierro EJ; Metelitsa LS
J Immunol; 2018 Oct; 201(7):2141-2153. PubMed ID: 30111631
[TBL] [Abstract][Full Text] [Related]
16. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
17. [Expansion and cytokine secretion profile of human valpha24(+) NKT cells from different sources].
Zhai WH; Huang Y; Wang M; Zhou Z; Zhai WJ; Zhang RL; Zhang P; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):633-6. PubMed ID: 19549378
[TBL] [Abstract][Full Text] [Related]
18. Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy.
Takahashi T; Haraguchi K; Chiba S; Yasukawa M; Shibata Y; Hirai H
Br J Haematol; 2003 Jul; 122(2):231-9. PubMed ID: 12846891
[TBL] [Abstract][Full Text] [Related]
19. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
Gordon EJ; Kelkar V
Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
[TBL] [Abstract][Full Text] [Related]
20. High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes.
Oikawa Y; Shimada A; Yamada S; Motohashi Y; Nakagawa Y; Irie J; Maruyama T; Saruta T
Diabetes Care; 2002 Oct; 25(10):1818-23. PubMed ID: 12351484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
